Today's Top Stories | | By Chris Markoch | July 30, 2026 01:25 PM |
| | | By Thomas Hughes | July 30, 2026 11:40 AM |
| | By Sam Quirke | July 30, 2026 11:05 AM |
| | | By Chris Markoch | July 30, 2026 07:35 AM |
| | By Jeffrey Neal Johnson | July 29, 2026 08:05 AM |
|
|
Analysts' Upgrades | | Adient (NYSE:ADNT) was upgraded by BNP Paribas Exane from "neutral" to "outperform". They now have a $26.00 price target on the stock. This represents a 18.6% upside from the current price of $21.93. | | Athira Pharma (NASDAQ:LONA) was upgraded by Citizens Jmp from "market perform" to "outperform". They now have a $18.00 price target on the stock. This represents a 146.9% upside from the current price of $7.29. | | Bloom Energy (NYSE:BE) was upgraded by Mizuho from "neutral" to "outperform". They now have a $242.00 price target on the stock, down from $285.00. This represents a 16.8% upside from the current price of $207.19. | | Core Scientific (NASDAQ:CORZ) was upgraded by Keefe, Bruyette & Woods from "market perform" to "outperform". They now have a $28.00 price target on the stock, up from $25.00. This represents a 28.4% upside from the current price of $21.81. | | Garrett Motion (NASDAQ:GTX) was upgraded by Deutsche Bank Aktiengesellschaft from "hold" to "buy". They now have a $36.00 price target on the stock, up from $33.00. This represents a 16.1% upside from the current price of $31.01. | | Grupo Aeroportuario del Sureste (NYSE:ASR) was upgraded by HSBC Holdings plc from "hold" to "buy". They now have a $349.00 price target on the stock. This represents a 26.2% upside from the current price of $276.60. | | Humana (NYSE:HUM) was upgraded by Leerink Partners from "market perform" to "outperform". They now have a $513.00 price target on the stock. This represents a 39.9% upside from the current price of $366.66. | | Lemonade (NYSE:LMND) was upgraded by Keefe, Bruyette & Woods from "underperform" to "market perform". They now have a $48.00 price target on the stock. This represents a 1.5% downside from the current price of $48.74. | | Rio Tinto (NYSE:RIO) was upgraded by Berenberg Bank from "hold" to "buy". The current price is $97.13. | | Sprouts Farmers Market (NASDAQ:SFM) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $103.00 price target on the stock, up from $80.00. This represents a 18.6% upside from the current price of $86.85. | | Werner Enterprises (NASDAQ:WERN) was upgraded by Robert W. Baird from "neutral" to "outperform". They now have a $43.00 price target on the stock. This represents a 16.6% upside from the current price of $36.88. | | Werner Enterprises (NASDAQ:WERN) was upgraded by Susquehanna from "neutral" to "positive". They now have a $44.00 price target on the stock, down from $48.00. This represents a 19.3% upside from the current price of $36.88. |
|
View More Upgrades
|
Analysts' Downgrades | | Banc of California (NYSE:BANC) was downgraded by Brean Capital from "buy" to "neutral". The current price is $18.87. | | Banco Santander Brasil (NYSE:BSBR) was downgraded by JPMorgan Chase & Co. from "overweight" to "neutral". They now have a $6.00 price target on the stock, down from $6.50. This represents a 18.3% upside from the current price of $5.07. | | Capricor Therapeutics (NASDAQ:CAPR) was downgraded by LADENBURG THALM/SH SH from "buy" to "neutral". The current price is $4.19. | | Capricor Therapeutics (NASDAQ:CAPR) was downgraded by Cantor Fitzgerald from "overweight" to "neutral". They now have a $3.50 price target on the stock. This represents a 16.5% downside from the current price of $4.19. | | Capricor Therapeutics (NASDAQ:CAPR) was downgraded by Maxim Group from "buy" to "hold". The current price is $4.19. | | Cincinnati Financial (NASDAQ:CINF) was downgraded by Bank of America Corporation from "buy" to "neutral". They now have a $193.00 price target on the stock, down from $197.00. This represents a 10.5% upside from the current price of $174.73. | | Fiverr International (NYSE:FVRR) was downgraded by Oppenheimer Holdings, Inc. from "outperform" to "market perform". The current price is $9.20. | | Fiverr International (NYSE:FVRR) was downgraded by Scotiabank from "sector outperform" to "sector perform". They now have a $10.00 price target on the stock. This represents a 8.8% upside from the current price of $9.20. | | Intuitive Surgical (NASDAQ:ISRG) was downgraded by HSBC Holdings plc from "buy" to "hold". They now have a $391.00 price target on the stock. This represents a 10.8% upside from the current price of $352.97. | | Las Vegas Sands (NYSE:LVS) was downgraded by Argus from "buy" to "hold". The current price is $49.86. | | Masco (NYSE:MAS) was downgraded by Evercore Inc from "outperform" to "in-line". They now have a $78.00 price target on the stock. This represents a 7.9% upside from the current price of $72.27. | | NBT Bancorp (NASDAQ:NBTB) was downgraded by Stephens from "overweight" to "equal weight". They now have a $55.00 price target on the stock, up from $52.00. This represents a 3.9% upside from the current price of $52.93. | | Paymentus (NYSE:PAY) was downgraded by Robert W. Baird from "outperform" to "neutral". They now have a $34.00 price target on the stock. This represents a 2.6% downside from the current price of $34.90. | | Sanara MedTech (NASDAQ:SMTI) was downgraded by HC Wainwright from "buy" to "neutral". They now have a $35.00 price target on the stock, down from $36.00. This represents a 2.8% upside from the current price of $34.06. | | Stock Yards Bancorp (NASDAQ:SYBT) was downgraded by Hovde Group from "outperform" to "market perform". They now have a $90.00 price target on the stock, up from $82.00. This represents a 4.4% upside from the current price of $86.20. | | Stride (NYSE:LRN) was downgraded by William Blair from "outperform" to "market perform". The current price is $83.34. |
|
View More Downgrades
|
Analysts' New Coverage | | Actuate Therapeutics (NASDAQ:ACTU) is now covered by Rodman & Renshaw. They set a "buy" rating and a $6.00 price target on the stock. This represents a 412.8% upside from the current price of $1.17. | | AEON Biopharma (NASDAQ:AEON) is now covered by Lake Street Capital. They set a "buy" rating and a $1.00 price target on the stock. This represents a 291.8% upside from the current price of $0.26. | | Jersey Mike's (NYSE:JMKE) is now covered by Melius Research. They set a "buy" rating and a $30.00 price target on the stock. This represents a 38.6% upside from the current price of $21.65. |
|
View More New Coverage
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
|
